Literature DB >> 16267073

Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes.

Rhonda Cooper-DeHoff, Carl J Pepine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267073     DOI: 10.1093/eurheartj/ehi624

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  2 in total

Review 1.  Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.

Authors:  Rhonda M Cooper-DeHoff; Michael A Pacanowski; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

Review 2.  Utility of ranolazine in chronic stable angina patients.

Authors:  Pawan D Patel; Rohit R Arora
Journal:  Vasc Health Risk Manag       Date:  2008
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.